Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 200

1.

The clinical and diagnostic performance characteristics of the high sensitivity Abbott cardiac troponin I assay.

Collinson PO, Gaze D, Goodacre S.

Clin Biochem. 2015 Mar;48(4-5):275-81. doi: 10.1016/j.clinbiochem.2014.12.017. Epub 2014 Dec 27.

PMID:
25549978
3.

Diagnostic performance of four point of care cardiac troponin I assays to rule in and rule out acute myocardial infarction.

Palamalai V, Murakami MM, Apple FS.

Clin Biochem. 2013 Nov;46(16-17):1631-5. doi: 10.1016/j.clinbiochem.2013.06.026. Epub 2013 Jul 11.

PMID:
23850852
4.

Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction.

Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, Wild P, Genth-Zotz S, Warnholtz A, Giannitsis E, Möckel M, Bickel C, Peetz D, Lackner K, Baldus S, Münzel T, Blankenberg S.

JAMA. 2011 Dec 28;306(24):2684-93. doi: 10.1001/jama.2011.1896.

PMID:
22203537
6.

[Evaluation of dynamic cardiac troponin I concentrations and C-reactive protein in the monitoring of myocardial infarction in patients with repeated myocardial infarction].

Plak M, Orliński L, Łobos M, Ciesielczyk M, Wlazeł RN, Paradowski MT.

Pol Merkur Lekarski. 2010 Jun;28(168):444-9. Polish.

PMID:
20642101
7.

Very early diagnosis of chest pain by point-of-care testing: comparison of the diagnostic efficiency of a panel of cardiac biomarkers compared with troponin measurement alone in the RATPAC trial.

Collinson P, Goodacre S, Gaze D, Gray A; RATPAC Research Team.

Heart. 2012 Feb;98(4):312-8. doi: 10.1136/heartjnl-2011-300723. Epub 2011 Nov 10.

PMID:
22076016
8.

Performance of the Advia Centaur second-generation troponin assay TnI-Ultra compared with the first-generation cTnI assay.

van de Kerkhof D, Peters B, Scharnhorst V.

Ann Clin Biochem. 2008 May;45(Pt 3):316-7. doi: 10.1258/acb.2007.007209.

PMID:
18482922
9.

Normal plasma levels of cardiac troponin I measured by the high-sensitivity cardiac troponin I access prototype assay and the impact on the diagnosis of myocardial ischemia.

Venge P, Johnston N, Lindahl B, James S.

J Am Coll Cardiol. 2009 Sep 22;54(13):1165-72. doi: 10.1016/j.jacc.2009.05.051.

10.

Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay.

Apple FS, Simpson PA, Murakami MM.

Clin Biochem. 2010 Aug;43(12):1034-6. doi: 10.1016/j.clinbiochem.2010.05.014. Epub 2010 May 27.

PMID:
20510894
11.

Analytical performance and clinical decision limit of a new release for cardiac troponin I assay.

Moretti M, Pieretti B, Sisti D, Rocchi M, Gasperoni S.

Ann Clin Biochem. 2015 Jan;52(Pt 1):169-72. doi: 10.1177/0004563214529749. Epub 2014 Apr 7.

PMID:
24711561
12.

Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain.

Aldous SJ, Richards M, Cullen L, Troughton R, Than M.

CMAJ. 2012 Mar 20;184(5):E260-8. doi: 10.1503/cmaj.110773. Epub 2012 Jan 30.

13.

Optimal cut-off value for cardiac troponin I in ruling out Type 5 myocardial infarction.

Jørgensen PH, Nybo M, Jensen MK, Mortensen PE, Poulsen TS, Diederichsen AC, Mickley H.

Interact Cardiovasc Thorac Surg. 2014 May;18(5):544-50. doi: 10.1093/icvts/ivt558. Epub 2014 Jan 26.

PMID:
24468543
14.

The 99th percentile and imprecision of point-of-care cardiac troponin I in comparison to central laboratory tests in a large reference population.

Greiser A, Winter T, Mahfoud H, Kallner A, Ittermann T, Masuch A, Lubenow N, Kohlmann T, Greinacher A, Nauck M, Petersmann A.

Clin Biochem. 2017 Dec;50(18):1198-1202. doi: 10.1016/j.clinbiochem.2017.08.006. Epub 2017 Aug 10.

PMID:
28803961
15.
16.

Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.

Christenson RH, Peacock WF, Apple FS, Limkakeng AT Jr, Nowak RM, McCord J, deFilippi CR.

Contemp Clin Trials Commun. 2019 Feb 15;14:100337. doi: 10.1016/j.conctc.2019.100337. eCollection 2019 Jun.

17.

Assay-related issues in the measurement of cardiac troponins.

Panteghini M.

Clin Chim Acta. 2009 Apr;402(1-2):88-93. doi: 10.1016/j.cca.2008.12.037. Epub 2009 Jan 9.

PMID:
19168041
18.

European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay.

Krintus M, Kozinski M, Boudry P, Capell NE, Köller U, Lackner K, Lefèvre G, Lennartz L, Lotz J, Herranz AM, Nybo M, Plebani M, Sandberg MB, Schratzberger W, Shih J, Skadberg Ø, Chargui AT, Zaninotto M, Sypniewska G.

Clin Chem Lab Med. 2014 Nov;52(11):1657-65. doi: 10.1515/cclm-2014-0107.

PMID:
24897400
19.

Diagnosis of type 1 and type 2 myocardial infarction using a high-sensitivity cardiac troponin I assay with sex-specific 99th percentiles based on the third universal definition of myocardial infarction classification system.

Sandoval Y, Smith SW, Schulz KM, Murakami MM, Love SA, Nicholson J, Apple FS.

Clin Chem. 2015 Apr;61(4):657-63. doi: 10.1373/clinchem.2014.236638. Epub 2015 Feb 11.

20.

Determination of high-sensitivity cardiac troponin I 99th percentile upper reference limits in a healthy Korean population.

Ji M, Moon HW, Hur M, Yun YM.

Clin Biochem. 2016 Jul;49(10-11):756-61. doi: 10.1016/j.clinbiochem.2016.01.027. Epub 2016 Apr 9.

PMID:
27067595

Supplemental Content

Support Center